文献速递甲状腺疾病

单光子发射计算机断层成像用于多种准备措施后甲状腺放射性碘摄取的临床前评估

Single-Photon Emission Computed Tomography for Preclinical Assessment of Thyroid Radioiodide Uptake Following Various Combinations of Preparative Measures.
PubMed 文献 · Thyroid · 2016-08-11

研究用微型单光子发射计算机断层成像/计算机断层成像(microSPECT/CT)定量评估小鼠甲状腺碘摄取受碘给药途径、重组人促甲状腺激素(rhTSH)注射及低碘饮食(LID)的影响。结果显示全身途径给碘较口服使甲状腺碘摄取增高2.35倍,LID联合全身给碘较标准正常碘饮食/口服途径增高约5倍;在T3治疗小鼠中LID联合rhTSH使摄取较正常碘饮食/T3/rhTSH增高2.8倍并使甲状腺活性恢复至甲状腺功能正常动物水平。

要点

  • 全身途径给予放射性碘较口服使正常碘饮食小鼠甲状腺碘摄取增高2.35倍。
  • 低碘饮食联合全身给碘较标准正常碘饮食/口服途径使摄取增高约5倍。
  • T3治疗小鼠中低碘饮食联合rhTSH使摄取较正常碘饮食/T3/rhTSH增高2.8倍。

核心结论

  • 全身途径给予放射性碘较口服产生更高的甲状腺碘水平,尤其在低碘饮食小鼠中。
  • 数据强调低碘饮食在甲状腺功能正常及T3治疗并注射rhTSH小鼠中的重要性。
  • 作者认为 extrapolated to human patients 并结合分化型甲状腺癌患者准备临床指南,数据表明低碘饮食可增强T3治疗患者中rhTSH治疗的疗效。

研究设计与样本

  • 研究使用微型单光子发射计算机断层成像/计算机断层成像(microSPECT/CT)定量评估小鼠甲状腺碘摄取。
  • 比较甲状腺功能正常与三碘甲状腺原氨酸(T3)治疗小鼠,分别喂饲正常碘饮食(NID)或低碘饮食(LID),并给予或不给予重组人促甲状腺激素(rhTSH)。
  • 放射性示踪剂经静脉、皮下、腹腔或灌胃途径给药,并用Western blotting测量甲状腺钠/碘同向转运体表达水平。

主要发现

  • 全身途径给予放射性碘使正常碘饮食小鼠甲状腺碘蓄积较口服给药增高2.35倍。
  • 低碘饮食联合全身给碘使甲状腺碘摄取较标准正常碘饮食/口服途径进一步增高约5倍。
  • rhTSH注射刺激正常碘饮食的甲状腺功能正常与T3治疗小鼠甲状腺活性,但T3治疗小鼠摄取水平仍低于甲状腺功能正常小鼠。
  • T3治疗小鼠中低碘饮食联合rhTSH使摄取较正常碘饮食/T3/rhTSH小鼠增高2.8倍,并帮助甲状腺活性恢复至甲状腺功能正常动物等效水平。

临床怎么用

  • 作者认为, extrapolated to human patients 并结合分化型甲状腺癌患者准备的临床指南,低碘饮食可增强T3治疗患者中rhTSH治疗的疗效。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: MicroSPECT/CT imaging was used to quantitatively evaluate how iodide uptake in the mouse thyroid is influenced by (i) route of iodine administration; (ii) injection of recombinant human thyrotropin (rhTSH); and (iii) low iodide diet (LID) in euthyroid and triiodothyronine (T3)-treated mice. METHODS: Pertechnetate (99mTcO4-) and 123I thyroid uptake in euthyroid and T3-treated animals fed either a normal-iodine diet (NID) or an LID, treated or not with rhTSH, and radiotracer administered intravenously, subcutaneously, intraperitoneally or by gavage, were assessed using microSPECT/CT imaging. Western blotting was performed to measure sodium/iodide symporter expression levels in the thyroid. RESULTS: Systemic administration of radioiodide resulted in a higher (2.35-fold in NID mice) accumulation of iodide in the thyroid than oral administration. Mice fed LID with systemic radioiodide administration showed a further two-fold increase in thyroid iodide uptake to yield a ∼5-fold increase in uptake compared to the standard NID/oral route. Although rhTSH injections stimulated thyroid activity in both euthyroid and T3-treated mice fed the NID, uptake levels for T3-treated mice remained low compared with those for the euthyroid mice. Combining LID and rhTSH in T3-treated mice resulted in a 2.8-fold higher uptake compared with NID/T3/rhTSH mice and helped restore thyroid activity to levels equivalent to those of euthyroid animals. CONCLUSIONS: Systemic radioiodide administration results in higher thyroidal iodide levels than oral administration, particularly in LID-fed mice. These data highlight the importance of LID, both in euthyroid and T3-treated, rhTSH-injected mice. Extrapolated to human patients, and in the context of clinical guidelines for the preparation of differentiated thyroid cancer patients, our data indicate that LID can potentiate the efficacy of rhTSH treatment in T3-treated patients.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Zwarthoed C, Chatti K, Guglielmi J, et al. Single-Photon Emission Computed Tomography for Preclinical Assessment of Thyroid Radioiodide Uptake Following Various Combinations of Preparative Measures. Thyroid. 2016. PMID: 27349131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。